Clinical trial Recruiting at 1 site Observational Ages 18 to 65

Understanding genetic factors that affect weight loss after bariatric surgery

Official title: Genetic Susceptibility to Predict Weight Loss After Bariatric Surgery

Run by Institut de Recerca Biomèdica de Lleida · NCT06226194 · Data updated 2026-11-12

This study is trying to find out if certain genes can help predict how well people with severe obesity will lose weight after having bariatric surgery.

Quick facts

Study typeObservational
Ages18 Years to 65 Years
SexAll
Enrollment6966 (estimated)
SponsorInstitut de Recerca Biomèdica de Lleida
Academic / other
Locations1 site (Lleida, Leida)
StatusRecruiting
StartedMarch 15, 2024
Main results expectedMarch 15, 2027
Study endsNovember 29, 2028
Registry record updatedMarch 6, 2024
Trial IDNCT06226194 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are men and women aged 18 to 65 with a BMI of 35 or higher and related comorbidities, or a BMI over 40.

Probably not a fit

Patients with previous gastrointestinal surgeries or those with severe medical conditions that limit healthy living may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to identify genetic markers that predict weight loss outcomes in patients undergoing bariatric surgery, specifically sleeve gastrectomy or gastric bypass. By analyzing a large cohort of nearly 7,000 individuals with severe obesity, the study will utilize a multi-omics approach to discover and validate these markers. The goal is to better understand why some patients respond well to surgery while others do not, which could lead to more personalized treatment strategies for obesity. The study will also include an external validation set to enhance the reliability of the findings.

Why it matters

Potential benefit: If successful, this study could lead to improved patient selection for bariatric surgery, enhancing weight loss outcomes and reducing healthcare costs associated with ineffective treatments.

How similar studies have gone: Other studies have explored genetic factors in obesity treatment, but this specific multi-omics approach in a large cohort is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Men and women between the ages of 18 and 65 at the time of surgery
* SG or RYBP as bariatric procedure.
* With a BMI≥35.0 kg/m2 with one or more comorbidities or a BMI\>40.0 kg/m2 at the time of surgery.
* Provision of an informed consent form signed and personally dated by the patient.
* With available baseline data (anthropometric, analytical, surgical procedure, pharmacological therapies, and obesity-related comorbidities).

Exclusion Criteria:

* Any previous gastrointestinal surgery
* Treatment with any approved antiobesity drug in Spain (orlistat, liraglutide 3.0 mg and/or naltrexone/bupropion extended release) or systemic glucocorticoids for more than 4 consecutive weeks during the 3 years following BS
* End stage kidney disease (eGFR \<15 ml/min/1.73m2) or liver cirrhosis at baseline
* Patients who developed any major medical conditions that limits the practice of a healthy life within normal limits (advanced cardiovascular disease or heart failure, stroke with neurological sequelae, chronic pulmonary obstructive disease with dyspnea at minimal exertion, severe joint pathology, end stage renal failure, or active cancer)
* Known type 1 diabetes or LADA diabetes
* Women who become pregnant during the follow-up period
* Current drug or alcohol abuse
* Uncontrolled psychiatric illness or eating disorders developed during the follow-up period.

Where it's running

  • IRBLleida
    Lleida, Leida, Spain
    Recruiting

Study contacts

  • Principal investigator: Miguel Angel Rubio, PhD — Instituto de Investigación Sanitaria Hospital Clínico San Carlos
  • Study coordinator: Albert Lecube Torelló, PhD
  • Email: alecube@gmail.com
  • Phone: 0034973705183

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.